FDA Announces Shortage of Adderall

FDA posted a shortage of the immediate release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall or Adderall IR.

Source: FDA Center for Drug Evaluation and Research - What's New - October 12, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news